Product Name | MF | CAS | Details |
---|
1-PeCSO | C6H11NO3S | 3836-24-6 | Details |
BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
Tepotinib hydrochloride(1 : x) | C29H29ClN6O2 | 1103508-80-0 | Details |
2-Amino-7-cyclopropyl methyl-7,8-dihydro-8-oxo-9-(beta-D-xylo furanosyl)purine | C14H19N5O5 | 2389988-30-9 | Details |
20-HETE inhibitor-1 | 2472030-28-5 | Details |
AMPK-α1β1γ1 activator 1 | 1943510-86-8 | Details |
Rifamycin S | C37H45NO12 | 13553-79-2 | Details |
ASP1126 | C26H26ClF6NO5 | 1228580-11-7 | Details |
N-Fmoc-aminohexyl P-methyl phosphonamidite | C28H41N2O3P | 128745-89-1 | Details |
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro guanosine | C13H14FN5O5 | 2389988-55-8 | Details |
3’-Azido-3’-deoxyinosine | 946497-27-4 | Details |
Cardiotoxin Analog (CTX) IV (6-12) TFA | 2918768-05-3 | Details |
Aβ42-IN-1 free base | C29H26N4O2 | 2434633-17-5 | Details |
1,2-Di-O-acetyl-3,5-di-O-benzyl-D-xylofuranose | C23H26O7 | 146986-45-0 | Details |
2’-Deoxy-2’-fluoro-5-methyl-araobinocytidine ?5’-triphosphate triethyl ammonium salt(79570-62-0 free base) | C10H17FN3O13P3 | 79570-62-0 | Details |
RR-src acetate | 2986315-28-8 | Details |
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | 2863687-18-5 | Details |
Anticancer agent 101 | 2914922-80-6 | Details |
5’-Deoxy-5’-N-methylaminothymidine | Details |
BAY-7598 | C28H31N3O6 | 1816257-74-5 | Details |
Loteprednol Etabonate-d5 | C24H31ClO7 | 2026643-11-6 | Details |
Antitumor agent-19 | C24H21ClF3N5O | 2379727-90-7 | Details |
5-Aza-3’-deoxycytidine | C8H12N4O4 | 455951-65-2 | Details |
Compound 2389988-36-5 | C14H17N5O8 | 2389988-36-5 | Details |
BPH-1358 free base | C32H28N6O2 | 801985-13-7 | Details |
anti-TB agent 1 | C23H19F3N4O3 | 2294013-78-6 | Details |
(1R)-Deruxtecan | C52H56FN9O13 | 2270986-87-1 | Details |
GSK778 hydrochloride | 2863657-79-6 | Details |
Antibacterial agent 160 | 1854892-66-2 | Details |
2-C-methylene-myo-inositol oxide | C7H12O6 | 4068-87-5 | Details |
1-[(5E)-5,6-Dideoxy-6-(diethoxyphosphinyl)-2-O-(2-methoxy ethyl)-β-D-ribo-hex-5-enofuranosyl]-5-methyluracil | C18H29N2O9P | 1345562-43-7 | Details |
BY27 | C22H21ClN6 | 2247236-59-3 | Details |
Autotaxin-IN-5 | C30H29N9O2 | 2156655-99-9 | Details |
AHR antagonist 4 | C20H14F6N4O4 | 2242465-58-1 | Details |
N2,N2-Dimethylamino-6-deamino adenosine | C12H17N5O4 | 105208-35-3 | Details |
H-PRO-HIS-CYS-LYS-ARG-MET-OH acetate | 2918771-43-2 | Details |
N4-Benzoyl-1-(6-O-DMTr-2,3-dideoxy-beta-D-erythro-hexopyranosyl)cytosine | C38H37N3O7 | 145594-00-9 | Details |
Anticancer agent 107 | 2397573-96-3 | Details |
2-Quinizarincarboxylic acid | C15H8O6 | 6416-55-3 | Details |
Autotaxin-IN-4 | C22H21N9O2 | 2156655-86-4 | Details |
Antitumor agent-2 | C33H42N4O4 | 1351163-57-9 | Details |
BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
Lys-Bradykinin acetate(342-10-9 free base) | C56H85N17O12.4C2H4O2 | 84640-50-6 | Details |
ABBV-712 | 2368945-27-9 | Details |
Abetimus | 167362-48-3 | Details |
2R-[(4,4’-Dimethoxy trityloxy)methyl]oxirane | C24H24O4 | 171406-50-1 | Details |
Aniline-MPB-amino-C3-PBD | C42H46N8O6 | 2412923-79-4 | Details |
5-(2-Hydroxyethyl)cytidine | C11H17N3O6 | 137248-64-7 | Details |
TRV-120027 acetate (1234510-46-3 free base) | 1824712-70-0 | Details |
7Ethanol-10NH2-11F-Camptothecin | 2873460-31-0 | Details |
AR453588 hydrochloride | C25H26ClN7O2S2 | 1065606-97-4 | Details |
1-Palmitoyl-2-succinyl-sn-glycerophosphorylcholine | C28H54NO10P | 89947-80-8 | Details |
(2E,9Z)-Octadeca-2,9-dienoic acid | C18H32O2 | 182369-03-5 | Details |
(R)-Monlunabant | 2765579-76-6 | Details |
Milnacipran-d5 HCl | 2750534-79-1 | Details |
BSc5371 | C24H31N5O4S | 2286419-03-0 | Details |
Antifungal agent 2 | C19H11Br2F3N4O2 | 2211060-61-4 | Details |
Activated EG3 Tail | C43H47N3O10 | 1380600-06-5 | Details |
2-Acetylamino-1-{3’-O-[(4,4’-dimethoxy triphenyl)methyl]-a-L-threo furanosyl}-6-(N,N-diphenylcarbamoyloxy)-9H-purine | C45H40N6O8 | 325683-92-9 | Details |
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-xylofuranosyl)purine | C13H15N5O5 | 2389988-53-6 | Details |
TLR7 agonist 13 | C17H19N5O6 | 2389988-70-7 | Details |
Methyl ? 3’-O-benzyl xyloriboside | C13H18O5 | 201014-45-1 | Details |
Aminooxy CatB-LXR | C52H66F3N7O11S | 1779524-93-4 | Details |
BET-IN-6 | C22H20N2O6S | 2570470-39-0 | Details |
1-(2,3-Dideoxy-2,3-didehydro-a-D-erythro-hexo pyranosyl) cytosine | C10H13N3O4 | 199599-71-8 | Details |
Alpha-5-Methyluridine | C10H14N2O6 | 3258-09-1 | Details |
3’-O-Acetyl-2’-deoxyuridine | C11 H14 N2 O6 | 23197-88-8 | Details |
(E)-5-Octadecene | C18H36 | 7206-21-5 | Details |
Patamostat HCl | 3031765-17-7 | Details |
5-n-Heptyl-6-hydroxy-4,7-dioxobenzothiazole | C14H17NO3S | 611207-02-4 | Details |
8-Benzyloxy-9-(b-D-xylofuranosyl)guanine | C17H19N5O6 | 2389988-19-4 | Details |
2-Amino -7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,3,5-tri-O-actyl-xylofuranosyl)purine | C19H21N5O8 | 2389988-52-5 | Details |
Amidate-VC-PAB-MMAF | 2202782-90-7 | Details |
ALP/Carbonic anhydrase-IN-1 | 2091887-74-8 | Details |
AChE-IN-44 | 2758685-58-2 | Details |
(R)-FT709 | 2413991-75-8 | Details |
(1-OH)-Exatecan | 2894780-53-9 | Details |
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-2,5-di-O-acetyl-3-deoxy-3-fluoro-ribofuranosyl)purine | C17H18FN5O6 | 2389986-90-5 | Details |
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy-3’-fluoro-xylo-guanosine | C13H14FN5O5 | 2389988-56-9 | Details |
AB131 | C21H19NO6S | 720671-77-2 | Details |
5'-homocytidine | C10H15N3O5 | 55085-34-2 | Details |
4,27-Dimethyl withaferin A | C30H42O6 | 1777780-95-6 | Details |
(S)-9-(2,3-Dihydroxypropyl)-2-amino-6-chloropurine | C8H10ClN5O2 | 885322-01-0 | Details |
A1AT modulator 1 | C21H23FN2O3 | 2406205-61-4 | Details |
2’-O-Phthalimidopropyl uridine | C20H21N3O8 | 165381-44-2 | Details |
Adam-20-S | 2413880-52-9 | Details |
2’-O-(2-Cyanoethoxy) ? (diisopropylamino)phosphino-3’-O-(4,4’-dimethoxy triphenyl)methyl-N2-isobutyryl-(R)-9-(2,3-dihydroxypropyl)-guanine | C42H52N7O7P | 182625-78-1 | Details |
7,8-Dihydro-8-oxo-7-propargyl-3’-deoxy guanosine | C13H15N5O5 | 2389988-54-7 | Details |
1-alpha-D-(3-Meth oxynaphthalen-2-yl)-2’-deoxy riboside; (1S)-1,4-Anhy dro-2-deoxy-1-C-(3-methoxy)-naphthalenyl)-D-erythro-pentitol | C16H18O4 | 1502811-53-1 | Details |
1-[3’-O-[(4,4’-dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N6-benzoyladenine | C37H33N5O6 | 325683-88-3 | Details |
2’-O-Phthalimidopropyl cytidine | C20H22N4O7 | 165381-50-0 | Details |
7'-Hydroxy ABA | C15 H20 O5 | 91897-25-5 | Details |
Antitrypanosomal agent 2 | C17H13N5O3 | 475626-30-3 | Details |
2-Amino-7-propargyl-7,8-dihydro-8-oxo-9-(beta-D-3-deoxy-ribofuranosyl)purine | C13H15N5O4 | 2389988-75-2 | Details |
Antibiofilm agent-2 | 2977230-63-8 | Details |
10NH2-11F-Camptothecin | 2873460-30-9 | Details |
Compound 2389988-38-7 | C14H17N5O7 | 2389988-38-7 | Details |
2-Amino-8-hydroxypurine-9-beta-D-(2’,5’-di-O-acetyl-3’-deoxy)riboside | C14H17N5O6 | 2389988-74-1 | Details |
(S)-(-)-MRJF22 | 2757301-90-7 | Details |
(αR)-Cyclopropaneacetamide-Exatecan | C29H28FN3O6 | 2414254-37-6 | Details |
Product Total: Product Page: | ||||
139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |